TMC
NXTM

Trellus Management Company’s NxStage Medical Inc. NXTM Stock Holding History

Trellus Management Company’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-80,000
Closed -$2.2M – 96
2017
Q3 		$2.2M Buy
+80,000
New +$2.13M 3.02% 6

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trellus Management Company's NXTM Position: Q3 2015 in Review

Trellus Management Company sold out of NxStage Medical Inc. (NXTM) in Q3 2015, closing a stake of 50,000 shares — an estimated $714K sold.

Trellus Management Company first reported a position in NXTM in Q4 2013 and held it in 5 quarters. The position peaked at $714K in Q2 2015. 127 funds tracked by Wall St. Rank hold NXTM as of Q3 2015.

  • Trellus Management Company reported no remaining NxStage Medical Inc. position as of Q3 2015 after selling out during the quarter.
  • Trellus Management Company sold 50,000 NxStage Medical Inc. shares in Q3 2015, an estimated $714K.
  • Trellus Management Company first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 5 quarters.
  • Trellus Management Company's NxStage Medical Inc. position peaked at $714K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2015.

Based on Trellus Management Company's 13F filing for Q3 2015, filed 14 Oct 2015.